GeneNews Ltd. | Cash Flow

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
9,406.40
7,676.70
7,697.70
7,831.70
3,825.70
5,111.90
Depreciation, Depletion & Amortization
293.50
19.30
5.50
452.80
450.90
402.90
Other Funds
52.30
-
-
-
-
181
Funds from Operations
5,181.40
1,367.90
3,201.50
4,518.90
5,788.90
4,890.10
Changes in Working Capital
564.20
393.80
993.60
360.50
612.00
189.30
Net Operating Cash Flow
4,617.20
1,761.70
2,207.90
4,879.50
5,176.80
4,700.80
Capital Expenditures
16.90
3.80
1.00
-
-
Sale of Fixed Assets & Businesses
-
-
-
31.20
-
Purchase/Sale of Investments
253.70
5,437.00
3,288.30
76.30
-
Net Investing Cash Flow
236.80
5,440.80
3,289.30
45.00
-
Issuance/Reduction of Debt, Net
437.50
285.10
511.80
1,895.40
2,698.80
Net Financing Cash Flow
489.80
7,180.00
3,141.90
4,524.70
4,952.80
Net Change in Cash
4,805.20
485.00
2,332.30
399.80
224.10
Free Cash Flow
4,634.10
1,765.50
2,208.90
4,879.50
5,176.80
Change in Capital Stock
-
7,465.10
2,630.10
2,629.30
2,254.00
Exchange Rate Effect
65.00
462.50
23.10
-
-

About GeneNews

View Profile
Address
70 East Beaver Creek Road
Richmond Hill Ontario L4B 3B2
Canada
Employees -
Website http://www.stagezerolifesciences.com
Updated 07/08/2019
GeneNews Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for early detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K.